Apontis Pharma AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	11.38	15.45	26.82	36.35	29.84	8.06
Cash & Short-Term Investments	11.38	15.45	26.82	36.35	29.84	8.06
Cash Growth	-29.58%	-42.37%	-26.22%	21.80%	270.28%	9.10%
Accounts Receivable	1.86	0.07	0.85	2.35	2.92	1.23
Other Receivables	-	0.09	0.23	0.03	0.07	0.03
Receivables	1.86	0.15	1.08	2.38	2.99	1.25
Inventory	6.89	6.52	6.62	3.16	4.6	2.92
Other Current Assets	0.88	0.67	0.59	0.54	0.59	0.64
Total Current Assets	21.01	22.79	35.11	42.43	38.02	12.88
Property, Plant & Equipment	0.01	0.02	0.03	0.04	0.02	0.04
Long-Term Investments	0.87	0.86	0.8	0.74	0.69	0.64
Other Intangible Assets	11.37	12.05	3.74	5.53	3.89	5.41
Long-Term Deferred Tax Assets	2.22	2.4	3.46	-	0.18	0.75
Other Long-Term Assets	8.5	6.25	14.33	11.06	11.24	9.95
Total Assets	43.99	44.37	57.46	59.85	54.13	29.69
Accounts Payable	2.8	4.75	5.09	5.36	3	3.26
Accrued Expenses	3.39	3.5	10.36	6.39	5.44	4.93
Short-Term Debt	-	-	6.02	-	-	-
Current Income Taxes Payable	0.06	0.06	0.83	1.23	0.38	-
Other Current Liabilities	1.63	0.86	1.02	1.15	1.21	0.84
Total Current Liabilities	7.88	9.17	23.31	14.13	10.03	9.04
Long-Term Debt	-	-	-	-	-	14.01
Pension & Post-Retirement Benefits	2.55	2.55	2.86	2.69	2.42	2.26
Long-Term Deferred Tax Liabilities	-	-	-	0.07	-	-
Other Long-Term Liabilities	1.94	1.64	1.03	1.4	0.97	0.92
Total Liabilities	12.37	13.36	27.2	18.29	13.42	26.23
Common Stock	8.5	8.5	8.5	8.5	8.5	0.03
Retained Earnings	-11.32	-11.93	-12.68	-1.38	-4.06	-3.32
Treasury Stock	-0.17	-0.17	-0.17	-0.17	-	-
Comprehensive Income & Other	34.61	34.61	34.61	34.61	36.28	6.75
Shareholders' Equity	31.62	31.02	30.26	41.57	40.71	3.46
Total Liabilities & Equity	43.99	44.37	57.46	59.85	54.13	29.69
Total Debt	-	-	6.02	-	-	14.01
Net Cash (Debt)	11.38	15.45	20.8	36.35	29.84	-5.95
Net Cash Growth	-29.58%	-25.69%	-42.78%	21.80%	-	-
Net Cash Per Share	1.37	1.86	2.50	4.36	3.51	-0.92
Filing Date Shares Outstanding	8.33	8.33	8.33	8.33	8.5	6.5
Total Common Shares Outstanding	8.33	8.33	8.33	8.33	8.5	6.5
Working Capital	13.13	13.63	11.79	28.3	27.99	3.84
Book Value Per Share	3.80	3.72	3.63	4.99	4.79	0.53
Tangible Book Value	20.25	18.97	26.53	36.04	36.82	-1.96
Tangible Book Value Per Share	2.43	2.28	3.18	4.33	4.33	-0.30
Machinery	-	0.7	0.69	0.66	0.6	0.59
Leasehold Improvements	-	-	-	0.02	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.